Gilead's Veklury wins expanded FDA nod for moderate COVID-19 patients despite mixed data
admin 31st August 2020 Uncategorised 0 Gilead’s Veklury wins expanded FDA nod for moderate COVID-19 patients despite mixed data
esagonowsky
Mon, 08/31/2020 – 11:27
More: Gilead's Veklury wins expanded FDA nod for moderate COVID-19 patients despite mixed data
Source: fierce